Emily M. Ko, MD, MSCR

Gynecologic Oncology
Accepting new patients
Sees patients age 18 and up
Penn Gynecologic Oncology Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366
Headshot of Emily M. Ko, MD, MSCR
Penn Medicine Provider

About me

  • Medical Director, Pennsylvania Hospital Abramson Cancer Center
  • Director, Gynecologic Oncology Populations Sciences Research Program
  • Director, REACH--Research Equity Center for Gynecologic Cancers and Health
  • Gynecologic Oncology Fellowship: Associate Program Director
  • Senior Fellow, Leonard Davis Institute for Health Economics
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

My education and training

  • Medical School: University of Massachusetts at Boston
  • Residency: Mass General Brigham Healthcare Center - Chestnut Hill
  • Fellowship: University of North Carolina at Chapel Hill

Spoken languages

English
English
Español
Spanish
中文 / 普通话
Chinese - Mandarin

Reviews

Average Rating

343 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
address my concerns going forward
Anonymous
May 2026
she is professional & empathetic
Anonymous
May 2026
very thorough in her explanations of what needs to take place in order to move forward with a precise diagnosis. dr. ko is extremely knowledgeable and i felt very comfortable.
Anonymous
April 2026
dr. ko has provided the best and most updated care.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Ko is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Ko E, Funk MJ, Clark L, Brewster W Did GOG99 and Portec1 Change Clinical Practice in the United States? , Gynecol Oncol, 129(1):12-17: 2013

Smith AJB, Alvarez R, Heintz J, Haggerty A, Ko EM Disparities in biomarker testing in ovarian cancer: a real-world analysis. , Am J Obstet Gynecol, 228(1):98-100: 2023

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM Prior authorization in gynecologic oncology: An analysis of clinical impact. , Gynecol Oncol, 167(3):519-522: 2022

Hicks-Courant K, Kanter GP, Schapira MM, Brensinger CM, Liu Q, Ko EM Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty. , Int J Gynecol Cancer , 32(6):695-703: 2022

Bodurtha Smith AJ, Pena D, Ko E Insurance-Mediated Disparities in Gynecologic Oncology Care. , Obstet Gynecol, 139(2):305-312: 2022

Saris DH, Bodurtha Smith AJ, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM Disparities in Cancer-Specific and Overall Survival in Black Women with Endometrial Cancer: A Medicare-SEER Study. , Gynecol Oncol Report, 40:100922: 2022

Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers. , Gynecol Oncol, 164(2):295-30: 2022

Aviki EM, Schleicher SM, Boyd L, Liang M, Ko EM, Zanotti K, Moss H The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. , Gynecol Oncol, 162(3):529-531: 2021

Latif N, Oh J, Brensinger C, Morgan M, Lin L, Cory L, Ko EM Lymphadenectomy is Associated with an Increased Risk of Postoperative Venous Thromboembolism in Early Stage Endometrial Cancer. , Gynecol Oncol, 161(1):130-134: 2021

Ko EM, Brensinger CM, Cory L, Giuntoli 2nd RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. , Gynecol Oncol, 159(2):394-401: 2020